Marker expression studies indicated that crystal cell differentiation is reduced in srpC.Scer\UAS; Scer\GAL4lz-gal4 embryos.
srpNC.Scer\UAS; Scer\GAL4lz-gal4 embryos have greatly reduced numbers of crystal cells at stage 13-16.
Scer\GAL4lz-gal4, srpNC.UAS has embryonic/larval crystal cell | embryonic stage phenotype, non-enhanceable by Scer\GAL4lz-gal4, ush1/ush1
Scer\GAL4lz-gal4, srpNC.UAS has embryonic/larval crystal cell phenotype, suppressible by lzUAS.cBa/Scer\GAL4lz-gal4
Scer\GAL4lz-gal4, srpNC.UAS has embryonic/larval crystal cell | embryonic stage phenotype, non-suppressible by Scer\GAL4lz-gal4, ush1/ush1
The reduction in crystal cell differentiation seen in srpC.Scer\UAS; Scer\GAL4lz-gal4 embryos is suppressed by lzScer\UAS.cBa.
The severe reduction in crystal cell numbers seen in srpNC.Scer\UAS; Scer\GAL4lz-gal4 embryos is unaffected by homozygosity for ush1.
Scer\GAL4twi.PG/srpNC.UAS partially rescues srp2
srpC.Scer\UAS; Scer\GAL4twi.PG can rescue plasmatocyte and crystal cell formation in srp2/srp2 embryos.